86
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Inhibition of heat-shock protein 90 sensitizes liver cancer stem-like cells to magnetic hyperthermia and enhances anti-tumor effect on hepatocellular carcinoma-burdened nude mice

, , , , , , , , & show all
Pages 7345-7358 | Published online: 07 Dec 2015

References

  • LiaoSHLiuCHBastakotiBPFunctionalized magnetic iron oxide/alginate core–shell nanoparticles for targeting hyperthermiaInt J Nanomed2015103315
  • OliveiraTRStaufferPRLeeCTMagnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry studyInt J Hyperthermia201329883584424050253
  • KossatzSGrandkeJCouleaudPEfficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug deliveryBreast Cancer Res20151716625968050
  • MorosMAmbrosoneAStepienGDeciphering intracellular events triggered by mild magnetic hyperthermia in vitro and in vivoNanomedicine (Lond)201510142167218325959578
  • CalderwoodSKHyperthermia, the tumor microenvironment and immunityTumor AblationKeisariYonaDordrecht, the NetherlandsSpringer20132937
  • DuncanRFInhibition of HSP90 function delays and impairs recovery from heat shockFEBS J2005272205244525616218955
  • YooDJeongHNohSHMagnetically triggered dual functional nanoparticles for resistance – free apoptotic hyperthermiaAngew Chem Int Ed201352491304713051
  • KaluarachchiWDCurleySAMultimodality therapy: enhancement of melanoma cell death with combination of heat shock protein 90 inhibitor, 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), and gold nanoparticles in a noninvasive radiofrequency fieldProceedings of Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy-Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 201020103409411
  • KatragaddaUFanWWangYCombined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysisPLoS One201383e5861923505544
  • YangZFHoDWNgMNSignificance of CD90+ cancer stem cells in human liver cancerCancer Cell200813215316618242515
  • ZhouJHuZLiZThe role of liver cancer stem cells in donor liver allocation for patients with hepatocellular carcinomaPostgrad Med20131256243024200758
  • BahnassyAAZekriAR NEl-BastawisyACirculating tumor and cancer stem cells in hepatitis C virus-associated liver diseaseWorld J Gastroenterol201420481824025561791
  • SadhukhaTNiuLWiedmannTSEffective elimination of cancer stem cells by magnetic hyperthermiaMol Pharm20131041432144123432410
  • LiYLiuJZhongYBiocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivoInt J Nanomed201162805
  • WangLZhangJAnYA study on the thermochemotherapy effect of nanosized As2O3/MZF thermosensitive magnetoliposomes on experimental hepatoma in vitro and in vivoNanotechnology2011223131510221730756
  • BootEPKoningGAStormGCD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritisArthritis Res Ther200573R604R61515899047
  • WuKSTangJTLiuXPreparation of magnetoliposomes and its in vivo behavior on ICR miceActa Pharm Sin2004394288291
  • YangRAnYLMiaoFQPreparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivoInt J Nanomed201494231
  • XieJYanCZhangYShape evolution of “multibranched” Mn–Zn ferrite nanostructures with high performance: a transformation of nanocrystals into nanoclustersChem Mater2013251837023709
  • SarviSMackinnonACAvlonitisNCD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonistCancer Res20147451554156524436149
  • DingJWuJEpigenetic regulation of hepatic tumor-initiating cellsFront Biosci (Landmark edition)201420946963
  • MaSChanKWHuLIdentification and characterization of tumorigenic liver cancer stem/progenitor cellsGastroenterology200713272542255617570225
  • MiyagawaTSaitoHMinamiyaYInhibition of HSP90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperatureInt J Clin Oncol201419472273023949287
  • KudryavtsevVAMakarovaYMKabakovAEThermosensitization of tumor cells with inhibitors of chaperone activity and expressionBiochem (Moscow) Suppl Ser B: Biomed Chem2012616167
  • OsakiMOkadaFOchiyaTmiRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrenceTher Deliv20156332333725853308
  • HaraguchiNIshiiHMimoriKCD13 is a therapeutic target in human liver cancer stem cellsJ Clin Invest20101209332620697159
  • Bañobre-LópezMTeijeiroARivasJMagnetic nanoparticle-based hyperthermia for cancer treatmentReports Pract Oncol Radiother2013186397400
  • MilaniVNoessnerEEffects of thermal stress on tumor antigenicity and recognition by immune effector cellsCancer Immunol Immunother200655331231916151807
  • TabuchiYKondoTTargeting heat shock transcription factor 1 for novel hyperthermia therapy (Review)Int J Mol Med20133213823636216
  • ChehabMCazaTSkotnickiKTargeting HSP90 in urothelial carcinomaOncotarget2015
  • DuncanRFInhibition of HSP90 function delays and impairs recovery from heat shockFEBS J2005272205244525616218955
  • HuangHCYangYNandaASynergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matricesNanomedicine20116345947321542685
  • XiaMHuangRSakamuruSIdentification of repurposed small molecule drugs for chordoma therapyCancer Biol Ther201314763864723792643
  • KalmarBLuCHGreensmithLThe role of heat shock proteins in amyotrophic lateral sclerosis: the therapeutic potential of ArimoclomolPharmacol Therap20141411405423978556